GLYC - GlycoMimetics' Uproleselan: Secondary Reasons To Own The Stock March, 16 2022 01:06 PM GlycoMimetics Inc. Investigator-sponsored trials keep piling up. Strength of indications beyond overall survival. Recent hiring spree of executives with commercial experience. Valuation, opportunity, and risk. For further details see: GlycoMimetics' Uproleselan: Secondary Reasons To Own The Stock